Skip to content

Author

Ziyuan Chen

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Targeting KLF4 Degradation by Doxycycline Restores Peroxisome Lipid Metabolism and Mitochondrial Energy Production in Acute Kidney Injury.

It is demonstrated that doxycycline directly binds KLF4 and promotes its ubiquitin-mediated degradation via the E3 ligase FBXO32, which restores ACOX3/IDH2-mediated fatty acid oxidation and the TCA cycle, enhancing cellular resilience against ischemic crisis.

Ji Feng, Zhiyuan Yao, Yu-Hong Li et al. · 0 citations
Review Jul 2026

Context-dependent roles of DHX9 in Cancer: Molecular mechanisms, biomarker potential, and therapeutic perspectives.

The molecular characteristics and regulatory properties of DHX9 are summarized, its roles in genome stability, transcriptional and post-transcriptional control, circular RNA biogenesis, and tumor-immune crosstalk are discussed, and its emerging value as a potential biomarker and therapeutic target is evaluated.

Yejin Cai, Ziyuan Chen, Jia-Ying Xiong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.